United States · FDA National Drug Code directory
Dexlansoprazole delayed release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24979-002_a73fe47b-b946-4d4c-8d5e-0aebbfd04a52
- Product NDC
- 24979-002
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- dexlansoprazole
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221201
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXLANSOPRAZOLE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-002-06) · 24979-002-06
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-002-07) · 24979-002-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →